Live encapsulated Lactobacillus acidophilus cells in yogurt for therapeutic oral delivery: Preparation and in vitro analysis of alginate-chitosan microcapsules

Canadian Journal of Physiology and Pharmacology

Volumn 85, Issue 9, 2007, Pages 884-893

  Urbanska, Aleksandra Malgorzata ^a   Bhathena, Jasmine ^a   Prakash, Satya ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Alginate; Artificial cells; Bacteria; Biotherapy; Chitosan; Microcapsule; Oral delivery; Probiotic; Yogurt

Indexed keywords

ALGINIC ACID; CHITOSAN; PROBIOTIC AGENT; YOGHURT;

ARTICLE; BACTERIAL CELL; BACTERIAL SURVIVAL; BACTERIAL VIABILITY; COMPUTER SIMULATION; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; GASTROINTESTINAL TRACT; LACTOBACILLUS ACIDOPHILUS; MICROCAPSULE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ALGINATES; CAPSULES; CHITOSAN; FEASIBILITY STUDIES; GASTROINTESTINAL TRACT; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; LACTOBACILLUS ACIDOPHILUS; MICROBIAL VIABILITY; PROBIOTICS; STRESS, MECHANICAL; YOGURT;

EID: 36549070569     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y07-057     Document Type: Article

References (24)

1. Awrey, D.E., Tse, M., Hortelano, G., and Chang, P.L. 1996. Permeability of alginate microcapsules to secretory recombinant gene products. Biotechnol. Bioeng. 52: 472-484. doi:10.1002/(SICI)1097-0290(19961120)52:4〈472:: AID-BIT3〉3.0.CO;2-M.
2. Chandramouli, V., Kailasapathy, K., Peiris, P., and Jones, M. 2004. An improved method of microencapsulation and its evaluation to protect Lactobacillus spp. in simulated gastric conditions. J. Microbiol. Methods, 56: 27-35. doi:10.1016/j.mimet.2003.09.002.
3. Chen, H., Ouyang, W., Lawuyi, B., and Prakash, S. 2006. Genipin cross-linked alginate-chitosan microcapsules: membrane characterization and optimization of cross-linking reaction. Biomacromolecules, 7: 2091-2098. doi:10.1021/bm050862y.
4. Conway, P.L., Gorbach, S.L., and Goldin, B.R. 1987. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J. Dairy Sci. 70: 1-12.
5. De, S.I., Van Hoorde, L., De Saeyer, M., Vande, W.M., and Verstraete, W. 1994. In vitro study of bile salt hydrolase (bsh) activity of bsh isogenic lactobacillus plantarem 80 strains an estimation of cholesterol lowering through enhanced bsh activity. Microb. Ecol. Health Dis. 7: 315-329.
6. De Boever, P., Deplancke, B., and Verstraete, W. 2000. Fermentation by gut microbiota cultured in a simulator of the human intestinal microbial ecosystem is improved by supplementing a soygerm powder. J. Nutr. 130: 2599-2606.
7. Decroos, K., Eeckhaut, E., Possemiers, S., and Verstraete, W. 2006. Administration of equol-producing bacteria alters the equol production status in the Simulator of the Gastrointestinal Microbial Ecosystem (SHIME). J. Nutr. 136: 946-952.
8. Feofilova, E.P. 1984. Biological functions and the practical use of chitin. Prikl. Biokhim. Mikrobiol. 20: 147-160.
9. Gupta, K.C., and Ravi Kumar, M.N. 2000. Drug release behavior of beads and microgranules of chitosan. Biomaterials, 21: 1115-1119. doi:10.1016/S0142-9612(99)00263-X.
10. Haque, T., Chen, H., Ouyang, W., Martoni, C., Lawuyi, B., Urbanska, A.M., and Prakash, S. 2005. Superior cell delivery features of poly(ethylene glycol) incorporated alginate, chitosan, and poly-L-lysine microcapsules. Mol. Pharm. 2: 29-36. doi:10.1021/mp049901v.
11. Ishibashi, N., and Shimamura, S. 1993. S. Bifidobacteria: research and development in Japan. Food Technol. 47: 126-135.
12. Knorr, D. 1984. Use of chitinous polymers in food - A challenge for food research and development. Food Technol. 38: 85-97.
13. Kurita, K. 2006. Chitin and chitosan: functional biopolymers from marine crustaceans. Mar. Biotechnol.(NY), 8: 203-226.
14. Molly, K., Vande, W.M., and Verstraete, W. 1993. Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem. Appl. Microbiol. Biotechnol. 39: 254-258.
15. Ouwehand, A., and Salminen, S. 1998. The health effects of cultured milk products with viable and non-viable bacteria. Int. Dairy J. 8: 749-758. doi:10.1016/S0958-6946(98)00114-9.
16. Possemiers, S., Verthé, K., Uyttendaele, S., and Verstraete, W. 2004. PCR-DGGE-based quantification of stability of the microbial community in a simulator of the human intestinal microbial ecosystem. FEMS Microbiol. Ecol. 49: 495-507.
17. Prakash, S., and Bhathena, J. 2005. Live bacterial cells as orally delivered therapeutics. Expert Opin. Biol. Ther. 5: 1281-1301. doi:10.1517/14712598.5.10.1281.
18. Richardson, S.C., Kolbe, H.V., and Duncan, R. 1999. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm. 178: 231-243. doi:10.1016/S0378-5173(98)00378-0.
19. Sun, A.M., Goosen, M.F., and O'Shea, G. 1987. Microencapsulated cells as hormone delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 4: 1-12.
20. Synowiecki, J., and Al-Khateeb, N.A.A.Q. 1997. Mycelia of Mucor rouxii as a source of chitin and chitosan. Food Chem. 60: 605-610. doi:10.1016/S0308-8146(97)00039-3.
21. Tan, S.C., Tan, T.K., Wong, S.M., and Khor, E. 1996. The chitosan yield of Zygomycetes at their optimum harvesting time. Carbohydr. Polym. 30: 239-242. doi:10.1016/S0144-8617(96)00052-5.
22. Uchegbu, I.F., Schatzlein, A.G., Tetley, L., Gray, A.I., Sludden, J., Siddique, S., and Mosha, E. 1998. Polymeric chitosan-based vesicles for drug delivery. J. Pharm. Pharmacol. 50: 453-458.
23. Uludag, H., De, V.P., and Tresco, P.A. 2000. Technology of mammalian cell encapsulation. Adv. Drug Deliv. Rev. 42: 29-64. doi:10.1016/S0169- 409X(00)00053-3.
24. Urbanska, A., Ouyang, W., Bhathena, J., and Martoni, C. 2006. Investigation of the viability of microencapsulated live Lactobacillus acidophilus cells for their use in probiotic yogurts. Int. J. Prebiotics Probiotics, 1: 33-37.